Business Information
The group's principal activities are to develop, manufacture and market innovative, research enabling tools used in drug discovery at pharmaceutical and biotechnology companies, universities and government laboratories. These tools are designed to accelerate the speed and to reduce the cost at which the group's customers can discover and commercialize new drugs. In Mar 1996, the group focussed on developing tools to alleviate two critical bottlenecks in the drug discovery process: proteomics during the target validation stage and admet screening during the secondary screening stage of the drug discovery process. The group sells these instruments, devices and consumables through its catalog, distributors and Web site. The group distributes most of its products directly through its operations in the United States, the United Kingdom, Germany, France and Canada on 03-Mar-2004, the group acquired kd scientific inc.
|
|
Name |
Title
|
Email
|
| David Parr | MD - Biochrom Business Unit | N/A | | David Strack | Pres. - Genomic Solutions, Inc, Union Biometrica INC | N/A | | Mark Norige | Pres. - Harvard Apparatus Business Unit | N/A | | Bryce Chicoyne | CFO | N/A | | Susan Luscinski | COO | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 76,181 | (2,341) | | 2005 | 67,431 | (31,877) | | 2004 | 92,597 | 2,329
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
